Medical Bulletin 04/September/2025 Anshika Mishra4 Sept 2025 3:00 PM ISTHere are the top medical news for the day:Hepatitis B Vaccine May Lower Diabetes Risk: Study FindsA new study to be presented at the Annual Meeting of...
Weight Loss Drugs May Lower Risk of Heart Failure Hospitalization and Death by 40 Percent: Study Anshika Mishra4 Sept 2025 8:30 AM ISTA new large-scale study published in JAMA and presented at the European Society of Cardiology Congress reveals that glucagon-like peptide-1 (GLP-1)...
Novo Nordisk's Wegovy, Fiasp, Ryzodeg Injectables Stolen During Transit, DCGI Issues Alert Susmita Roy23 Aug 2025 3:00 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) has issued an alert for doctors and healthcare professionals to carefully prescribe and...
From Breakthrough to Backlash: Novo Nordisk's Ozempic Faces USD 2 Billion Lawsuit Farhat Nasim22 Aug 2025 6:32 PM ISTNew Delhi: Novo Nordisk, the maker of the blockbuster diabetes drug Ozempic, is at the center of a brewing legal storm. Once celebrated as a...
Natco vs Novo Nordisk: Delhi High Court Directs Mediation in Wegovy Patent Dispute Farhat Nasim21 Aug 2025 9:26 PM ISTNew Delhi: Hyderabad-based Natco Pharma has filed a lawsuit against Danish drugmaker Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy...
Rs 180 Crore Ozempic Fraud: LOC Issued Against Pharma Firm CEO Parthika Patel20 Aug 2025 7:41 PM ISTNew Delhi: Delhi Police has issued a lookout circular (LOC) against Vicky Ramancha, Chief Executive Officer (CEO) of a pharmaceutical company, for...
Novo Nordisk Wegovy approved by USFDA for adults with noncirrhotic MASH with liver fibrosis Ruchika Sharma16 Aug 2025 12:45 PM ISTPlainsboro: Novo Nordisk has received approval from the US Food and Drug Administration (FDA) for a new indication for Wegovy...
Emcure Pharma Gets CDSCO Panel Nod for Phase III Trial of Semaglutide in Chronic Weight Management Susmita Roy13 Aug 2025 5:39 PM ISTNew Delhi: Accepting the bioequivalence (BE) study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Precise Biopharma Gets CDSCO Panel Nod To Conduct Phase III Trial of Semaglutide Injection Susmita Roy12 Aug 2025 12:47 PM ISTNew Delhi: Accepting the bioequivalence study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Tirzepatide superior to Semaglutide- SURMOUNT-5 Trial Results Deeksha Bhandari11 Aug 2025 12:54 PM IST In SURMOUNT-5 Treatment with tirzepatide MTD (10 or 15 mg) was superior to semaglutide MTD (1.7 or 2.4 mg) with respect to reduction in...
Indian pharma market registers 7.9 percent growth in July: Report MD Bureau9 Aug 2025 3:30 PM ISTNew Delhi: The Indian pharmaceutical market (IPM) registered a growth of 7.9 percent in July 2025, and cardiac and anti-diabetes therapy segments have...
CDSCO Panel Approves New Indications for Novo Nordisk's Semaglutide, Mandates PMS Study Susmita Roy9 Aug 2025 12:18 PM ISTNew Delhi: Recommending to conduct post marketing surveillance (PMS) study in India, the Subject Expert Committee (SEC) functional under the Central...
